Clinical trial
Management of Patent Ductus in Premature Infants
NCT00000494 · National Heart, Lung, and Blood Institute (NHLBI), NIH · Completed
Key facts
| NCT number | NCT00000494 |
|---|---|
| Title | Management of Patent Ductus in Premature Infants |
| Lead sponsor | National Heart, Lung, and Blood Institute (NHLBI), NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Cardiovascular Diseases, Defect, Congenital Heart, Ductus Arteriosus, Patent, Heart Diseases |
| Intervention type | Drug, Procedure |
| Interventions | indomethacin, surgery, cardiovascular |
| Start date | Sep 1, 1978 |
| Completion | Mar 1, 1982 |
| First posted | Oct 28, 1999 |
| Last update posted | Dec 13, 2013 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: